Astellas Opens Australian Sales Office To Promote In-House Products
This article was originally published in PharmAsia News
Astellas Pharma said it has set up an Australian sales affiliate in advance of its planned April launch of its Vesicare (solifenacin) drug for treating bladder problems
You may also be interested in...
Erectile dysfunction drug sildenafil, plus treatments for skin conditions such as eczema, are among a bounty of Rx-to-OTC switches approved in Switzerland.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?
Sandoz has appointed a new leader for its Japanese business following the acquisition of Aspen’s local operations, while Stada has brought in a former Sandoz and Pfizer executive to lead its Ciclum Farma unit in Portugal. Meanwhile, Julphar has a new CEO.